Cole J. Batty

Cole J. Batty

Auto-generated profile, based on publicly available information

Cole J. Batty

Division of Pharmacoengineering and Molecular Pharmaceutics Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill 27599 USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2022 in Bioengineering & Translational Medicine
Verified
Journal Article
Open access
RSRebeca T. Stiepel
Rebeca T. Stiepel
EDEliza Duggan
Eliza Duggan
CBCole J. Batty
Cole J. Batty
KAKristy M Ainslie
Kristy M Ainslie
The first publication of micro‐ and nanotechnology in medicine was in 1798 with the use of the Cowpox virus by Edward Jenner as an attenuated vaccine against Smallpox. Since then, there has been an explosion of micro‐ and nanotechnologies for medical applications. The breadth of these micro‐ and nanotechnologies is discussed in this piece, presenting the date of their first report and their latest progression (e.g., clinical trials, FDA approval). This includes successes such as the recent severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccines from Pfizer, Moderna, and Janssen (Johnson & Johnson) as well as the most popular nanoparticle therapy, liposomal Doxil. However, the enormity of the success of these platforms has not been without challenges. For example, we discuss why the production of Doxil was halted for several years, and the bankruptcy of BIND therapeutics, which relied on a nanoparticle drug carrier. Overall, the field of micro‐ and nanotechnology has advanced beyond these challenges and continues advancing new and novel platforms that have transformed therapies, vaccines, and imaging. In this review, a wide range of biomedical micro‐ and nanotechnology is discussed to serve as a primer to the field and provide an accessible summary of clinically relevant micro‐ and nanotechnology platforms.

20 December 2023 in Advanced Therapeutics
Verified
Journal Article
Closed access
DHDylan A. Hendy
Dylan A. Hendy
EPErik S. Pena
Erik S. Pena
CBCole J. Batty
Cole J. Batty
Luis Ontiveros-PadillaLuis Ontiveros-Padilla
Luis Ontiveros-Padilla
JIJohn A. Roque Iii
John A. Roque Iii
KAKristy M Ainslie
Kristy M Ainslie

19 January 2015 in Chemphyschem
Verified
Journal Article
Open access
PDF file
SLSong Lou
Song Lou
CBCole J. Batty
Cole J. Batty
Mika E.T. SillanpääMika E.T. Sillanpää
Mika E.T. Sillanpää
DDDuolong Di
Duolong Di
Click on the article title to read more.